Enlivex Therapeutics
ENLV
ENLV
20 hedge funds and large institutions have $8.79M invested in Enlivex Therapeutics in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
80% less call options, than puts
Call options by funds: $286K | Put options by funds: $1.42M
Holders
20
Holding in Top 10
–
Calls
$286K
Puts
$1.42M
Top Buyers
| 1 | +$342K | |
| 2 | +$89K | |
| 3 | +$22.8K | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$13.4K |
| 5 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$8K |
Top Sellers
| 1 | -$843K | |
| 2 | -$376K | |
| 3 | -$236K | |
| 4 |
GG
Golden Green
Seneca,
South Carolina
|
-$212K |
| 5 |
Goldman Sachs
New York
|
-$144K |